Mast	0	4	B-Cell
cells	5	10	I-Cell
and	11	14	O
tumors	15	21	B-Pathological_formation
.	21	22	O

The	23	26	O
specific	27	35	O
enhancement	36	47	O
of	48	50	O
tumor	51	56	B-Pathological_formation
proliferation	57	70	O
in	71	73	O
vitro	74	79	O
.	79	80	O

Mast	82	86	B-Cell
cells	87	92	I-Cell
were	93	97	O
found	98	103	O
to	104	106	O
be	107	109	O
unique	110	116	O
among	117	122	O
the	123	126	O
peritoneal	127	137	B-Cell
leukocytes	138	148	I-Cell
by	149	151	O
virtue	152	158	O
of	159	161	O
their	162	167	O
capacity	168	176	O
to	177	179	O
enhance	180	187	O
profoundly	188	198	O
the	199	202	O
proliferation	203	216	O
of	217	219	O
a	220	221	O
variety	222	229	O
of	230	232	O
tumors	233	239	B-Pathological_formation
in	240	242	O
vitro	243	248	O
.	248	249	O

This	250	254	O
phenomenon	255	265	O
occurs	266	272	O
at	273	275	O
mast	276	280	B-Cell
cell	281	285	I-Cell
/	285	286	O
tumor	286	291	B-Pathological_formation
ratios	292	298	O
which	299	304	O
reflect	305	312	O
the	313	316	O
stoichiometry	317	330	O
of	331	333	O
host	334	338	B-Cell
cell	339	343	I-Cell
/	343	344	O
tumor	344	349	B-Pathological_formation
relationships	350	363	O
in	364	366	O
vivo	367	371	O
.	371	372	O

The	373	376	O
growth	377	383	O
factor	384	390	O
was	391	394	O
found	395	400	O
to	401	403	O
reside	404	410	O
in	411	413	O
mast	414	418	B-Cell
cell	419	423	I-Cell
granules	424	432	B-Organism_substance
and	433	436	O
was	437	440	O
identified	441	451	O
as	452	454	O
heparin	455	462	B-Drug_or_compound
by	463	465	O
sequential	466	476	O
purification	477	489	O
and	490	493	O
enzymatic	494	503	O
degradation	504	515	O
.	515	516	O

This	517	521	O
cellular	522	530	O
interaction	531	542	O
was	543	546	O
tumor	547	552	B-Pathological_formation
-	552	553	O
specific	553	561	O
,	561	562	O
although	563	571	O
isolated	572	580	O
granules	581	589	B-Organism_substance
could	590	595	O
enhance	596	603	O
fibroblast	604	614	B-Cell
proliferation	615	628	O
.	628	629	O

The	630	633	O
findings	634	642	O
are	643	646	O
discussed	647	656	O
in	657	659	O
relation	660	668	O
to	669	671	O
previous	672	680	O
morphologic	681	692	O
studies	693	700	O
,	700	701	O
reports	702	709	O
of	710	712	O
in	713	715	O
vitro	716	721	O
mast	722	726	B-Cell
-	726	727	I-Cell
cell	727	731	I-Cell
-	731	732	O
mediated	732	740	O
tumor	741	746	B-Pathological_formation
cytotoxicity	747	759	O
,	759	760	O
and	761	764	O
the	765	768	O
role	769	773	O
of	774	776	O
mast	777	781	B-Cell
cells	782	787	I-Cell
in	788	790	O
angiogenesis	791	803	O
and	804	807	O
connective	808	818	B-Tissue
tissue	819	825	I-Tissue
proliferation	826	839	O
.	839	840	O

